Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
about
Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case reportTreatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism.Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone-Kidney-Gut Axis.Development of a 3D bone marrow adipose tissue model.
P2860
Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
@en
type
label
Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
@en
prefLabel
Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
@en
P2860
P356
P1433
P1476
Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder
@en
P2093
Susan C Schiavi
P2860
P304
P356
10.1111/SDI.12415
P577
2015-08-19T00:00:00Z